News room
Relevance for screening antibodies in a faster and more effcient way using Technophage’s patented technologies
Since the 1st January 2020, Technophage is a resident company of Johnson & Johnson Innovation, JLABS, a premier life science incubator program....
Healthcare associated infections in COVID-19 patients
COVID-19 patients suffering from severe forms of the disease are at risk of developing bacterial healthcare-associated infections, such as...
TechnoPhage is hiring for Head of Neuroscience
TechnoPhage is currently looking for a Head of Neuroscience/Ophthalmology (PhD) with a strong scientific background to lead a team dedicated to...
A new zebrafish drug screening platform enables an effective selection of new therapeutics for spinal cord injuries
Technophage S.A., in collaboration with a team led by Leonor Saúde, Principal Investigator of the Instituto de Medicina Molecular João Lobo Antunes...
New patent addressing Parkinson’s disease allowed in the USA
The United States Patent and Trademark Office recently issued a notice of allowance for US patent application number 15/568,655 covering...